Case File
efta-efta00346034DOJ Data Set 9OtherDS9 Document EFTA00346034
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00346034
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To: Jeffrey Epstein
Subject: Jeff Port
Date: Thu, 02 Jul 2015 19:38:50 +0000
Jeff is tentatively scheduled for 3pm on July 9th...I told him we will circle back next week.
On Jul 2, 2015, at 2:26 PM, jeffrey E. <
> wrote:
Forwarded message
From: Jeffrey Port <1
Date: Thu, Jul 2, 2015 at 7:37 PM
Subject: RE:
To: "jeffrey E."
Jeff
Can we do something early on the 9th
JP
From: jeffrey E. [mailto
Sent: Thursday, July 02, 2015 10:52 AM
To: Jeffrey Port
Subject: Re:
i will be back either the 9th or the 14th,
either day would be fine. look forward to meeting you
On Thu, Jul 2, 2015 at 4:41 PM, Jeffrey Port <
wrote:
Jeff
Hope all well
Wanted to provide the numbers for Angiocrine
In summary, we are heading out by summers end for a series B raise at a 50 million pre money valuation.
We are offering a 25% discount to the series b , and looking to bolster our financials for the raise with an
additional 5 million in capital.
Overall, I think a very good deal . Paul Finnegan , our CEO, and I are available next week in NY if you wish
to discuss live
EFTA00346034
If you have interest let me know
Best regards
Jeff Port
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to
and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to
and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00346035
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.